A report published in the January issue of Pediatrics journal may cause unfounded concerns about the safety of chiropractic for children, according to the World Chiropractic Alliance (WCA), an organization representing doctors of chiropractic around the world.
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston have discovered a toxin present in the bacteria responsible for the current nationwide outbreak of staph infections also has a role in an aggressive pneumonia that is often fatal within 72 hours.
Brain injury causes glutamate, a substance necessary for proper brain function, to flood areas surrounding the trauma and kill other cells. Weizmann Institute scientists have developed a new way to rid the brain of excess glutamate. This method — which uses an enzyme found in blood — could lead to new therapies not only for brain injury, but also for stroke and other conditions, and holds promise for prevention of damage from meningitis or nerve gas.
The test results received today from the student at Hopkins Hill Elementary School in Coventry who contracted meningitis showed no connection to the illnesses in Warwick and West Warwick.
Rhode Island State health officials in Rhode Island are preparing to open schools on Monday after a meningitis scare. They’ve also provided every school in the state with alcohol-based gels and dispensers.
A set of guidelines have been developed that can help predict the risk of bacterial meningitis for children with cerebrospinal fluid pleocytosis (presence of greater number of white blood cells than normal), reducing unnecessary hospitalizations and antibiotics, according to a study in the January 3 issue of JAMA.
A man found positive for a bacteria that causes meningitis. The man portrayed Santa Claus at the Southwyck Mall in Toledo on Dec. 15 and Dec. 18-20.
Researchers at the National Institutes of Health have developed an experimental vaccine that could, theoretically, eliminate malaria from entire geographic regions, by eradicating the malaria parasite from an area’s mosquitoes.
The National Institutes of Health (NIH) launched a new website today offering technologies available for commercial licensing that are related to rare diseases or conditions. The listing can be found at http://www.ott.nih.gov/rarediseases and currently consists of more than 500 such technologies, including drugs, biologics, and devices, available to be transferred from the NIH and the U.S. Food and Drug Administration (FDA) to the private sector for further research and development and potential commercialization.
A ?20 million Department of Health program to develop medicines specifically for use in children will be launched jointly by the University of Liverpool and the Royal Liverpool Children?s NHS Trust (Alder Hey) tomorrow (Thursday, 7 December).